Skip to main content
Nightingale Health Oyj logo

Nightingale Health Oyj — Investor Relations & Filings

Ticker · HEALTH ISIN · FI4000490875 LEI · 743700WUIPC24LVMLO66 ST Human health and social work activities
Open in API
Filings indexed 54 across all filing types
Latest filing 2026-03-05 Interim / Quarterly Rep…
Country FI Finland
Listing ST HEALTH

About Nightingale Health Oyj

https://nightingalehealth.com/

Nightingale Health is a preventative health company that has developed an advanced blood analysis technology platform. From a single blood sample, the platform provides comprehensive health insights and detects risks for multiple chronic diseases. The company's primary offerings are the "Nightingale Health Check" and the "Remote Health Check." These services are utilized by a wide range of partners, including healthcare providers, insurance companies, governments, consumer health services, and telehealth platforms. Additionally, Nightingale Health provides its mass-scale blood analysis technology to the medical research community, enabling large-scale metabolomics studies and collaborations with major biobanks to advance disease prevention and treatment.

Recent filings

Filing Released Lang Actions
NightingaleHealthOyj Puolivuotiskatsaus 1.7.2025 - 31.12.2025.pdf
Interim / Quarterly Report Classification · 1% confidence The document is a 'Puolivuotiskatsaus' (Half-year report) for Nightingale Health covering the period 1.7.2025–31.12.2025. It contains comprehensive financial statements, key performance indicators, management commentary, and operational highlights. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2025
2026-03-05 Finnish
Nightingale Healthin puolivuotiskatsaus: Kliinistä arvoa terveydenhuollolle ja kohti 50 % liikevaihdon kasvua vahvan myyntiputken tukemana
Interim / Quarterly Report Classification · 1% confidence The document is a 'puolivuotiskatsaus' (half-year report) for Nightingale Health Oyj covering the period 1.7.2025–31.12.2025. It contains comprehensive financial statements (IFRS), key performance indicators, management commentary, and operational updates. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2026
2026-03-05 Finnish
NightingaleHealthPlc Half-year report 1 Jul - 31 Dec 2025.pdf
Interim / Quarterly Report Classification · 1% confidence The document is a 'Half-Year Report' for Nightingale Health covering the period 1 July 2025 to 31 December 2025. It contains comprehensive financial statements (Revenue, EBITDA, Operating loss, Net loss, etc.), key performance indicators, and a detailed management discussion (CEO report). It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2025
2026-03-05 English
Nightingale Health's half-year report: Delivering clinical value for healthcare and moving toward 50% revenue growth, supported by a strong sales pipeline
Interim / Quarterly Report Classification · 1% confidence The document is a 'half-year report' for Nightingale Health, covering the period from 1 July 2025 to 31 December 2025. It contains comprehensive financial statements (Revenue, EBITDA, Operating loss, Net loss, EPS, etc.), a CEO review, and detailed operational updates. It is not a mere announcement of a report (RPA) or a certification, but the actual interim financial report itself, which fits the definition of an Interim / Quarterly Report (IR). H1 2026
2026-03-05 English
Sisäpiiritieto: Merkittävä edistysaskel Yhdysvalloissa - Nightingale Healthin New Yorkin laboratorio saanut kliinisen laboratorion luvan New Yorkin osavaltiolta
Regulatory Filings Classification · 1% confidence The document is a press release titled 'Sisäpiiritieto' (Inside Information) announcing that Nightingale Health has received a clinical laboratory license from the New York State Department of Health. It details the regulatory achievement, its impact on the company's US expansion, and the next steps in the licensing process. As it is a specific corporate announcement regarding regulatory status and business operations that does not fit into financial reporting or specific governance categories, it is classified as a Regulatory Filing (RNS).
2026-02-09 Finnish
Inside information: Nightingale Health achieves major milestone in the United States: New York laboratory now holds a clinical laboratory permit from New York State
Regulatory Filings Classification · 1% confidence The document is an 'Inside Information' announcement regarding a regulatory milestone (obtaining a clinical laboratory permit in New York). It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general regulatory announcement regarding company operations and compliance, it falls under the 'Regulatory Filings' (RNS) category.
2026-02-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.